SARS-CoV2 Immunity and Cell Biology

NIH Pandemic-Era Grants

Pandemic Era Grants

2023

↗ Live URL (may be dead)

Document text

Principal Investigator: Jonathan W Yewdell
Organization: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Fiscal Year: 2023
Award: $301,514
Funding agency: National Institute of Allergy and Infectious Diseases

We have generated Sleeping Beauty transposase vectors that drive expression of the SARS-CoV-2 receptor ACE2 and or protease TMPRSS2 in host cells and use these vectors to create permanent transfected lines of A549, 293FT, and BHK-21 cells.
We have generated a recombinant vesicular stomatitis virus that expresses a reporter fluorescent protein and SARS-CoV-2 spike protein in place of the normal viral receptor.  This virus allows us to perform highly accurate neutralization assays using anti-spike mAbs or polyclonal sera.  
We have generated several hundred mouse mAbs specific for SARS-CoV-2 spike protein and are in the process of defining their epitopes and biological activity.  For this effort, we are generating library in which each residue in spike is replaced with alanine.  The library will be used express spike via transfection or by an equivalent recombinant vesicular stomatitis library.
We are generating mAbs specific for SARS-CoV-2 nucleocapsid protein.
We have characterized the binding of dozens of chemokines to a number of SARS-CoV-2 proteins and have discovered a number of chemokines that bind with high affinity as determined by bio-layer interferometry.
We have created a system for generating recombinant seasonal CoVs or recombinant SARS-CoV-2.  We are creating seasonal CoVs that express SARS-CoV-2 spike in place of native spike to enable a more realistic neutralization assay.  We are also generating recombinant CoVs that express MHC class I peptides to enable studying the effects of CoV infection on the MHC class I antigen processing pathway.

Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV S protein><2019-nCoV spike glycoprotein><2019-nCoV spike protein><A549><ACE2><Affinity><Alanine><Antibody Specificity><Antigenic Determinants><Assay><Binding><Binding Determinants><Bioassay><Biologic Assays><Biological><Biological Assay><COVID-19 S protein><COVID-19 immunity><COVID-19 spike glycoprotein><COVID-19 spike protein><COVID-19 virus><COVID19 S protein><COVID19 immunity><COVID19 spike glycoprotein><COVID19 spike protein><COVID19 virus><Cell Body><Cells><Cellular biology><Chemotactic Cytokines><Class I Antigens><Class I Genes><Class I Major Histocompatibility Antigens><Clinical Treatment Moab><CoV-2><CoV2><Complex Class 1><Coronaviridae><Coronaviridae Infections><Coronavirus><Coronavirus Infections><Epitheliasin Gene><Epitopes><Esteroproteases><Goals><Histocompatibility Antigens Class I><Homologous Chemotactic Cytokines><Human><Intercrines><Interferometry><Libraries><MHC Class I><MHC Class I Genes><MHC Class I Molecule><MHC Class I Protein><MHC class I antigen><Major Histocompatibility Complex Class 1><Mice><Mice Mammals><Modern Man><Molecular Interaction><Monoclonal Antibodies><Murine><Mus><Nucleocapsid Proteins><PRSS10><Pathway interactions><Peptidases><Peptide Hydrolases><Process><Protease Gene><Proteases><Proteinases><Proteins><Proteolytic Enzymes><Proteome><Receptor Protein><Recombinants><Reporter><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 S protein><SARS-CoV-2 immunity><SARS-CoV-2 spike glycoprotein><SARS-CoV-2 spike protein><SARS-CoV2><SARS-CoV2 S protein><SARS-CoV2 spike glycoprotein><SARS-CoV2 spike protein><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><SIS cytokines><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 S protein><Severe acute respiratory syndrome coronavirus 2 immunity><Severe acute respiratory syndrome coronavirus 2 spike glycoprotein><Severe acute respiratory syndrome coronavirus 2 spike protein><Severe acute respiratory syndrome related corona virus 2><Sleeping Beauty><Stomatitis><System><TMPRSS2><TMPRSS2 gene><Transfection><Transposase><VSV><Vesicular Stomatitis Virus><Vesicular stomatitis Indiana virus><Viral Activity><Viral Function><Viral Physiology><Viral Receptor><Virus><Virus Receptors><Wuhan coronavirus><angiotensin converting enzyme 2><angiotensin converting enzyme II><antigen processing><biologic><cell biology><chemoattractant cytokine><chemokine><corona virus><coronavirus disease 2019 S protein><coronavirus disease 2019 immunity><coronavirus disease 2019 spike glycoprotein><coronavirus disease 2019 spike protein><coronavirus disease 2019 virus><coronavirus disease-19 virus><cytokine><hCoV19><immunity against COVID-19><immunity against COVID19><immunity against SARS-CoV-2><immunity against Severe acute respiratory syndrome coronavirus 2><immunity against coronavirus disease 2019><immunity to COVID-19><immunity to COVID19><immunity to SARS-CoV-2><immunity to Severe acute respiratory syndrome coronavirus 2><immunity to coronavirus disease 2019><mAbs><monoclonal Abs><nCoV2><pathway><peptide I><receptor><seasonal coronavirus><seasonal human coronavirus><translatome><vector>